[Inhibition of the progression of renal failure in glomerular diseases].
Ritz
E
E
Medizinische Universitäts-Klinik Heidelberg.
Siebels
M
M
Fliser
D
D
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004044:Dietary Proteins / Q000008:administration & dosage; D005921:Glomerulonephritis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy*; D007677:Kidney Function Tests; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004044:Dietary Proteins
Hemmung der Progression der Niereninsuffizienz bei glomerulären Erkrankungen.